2016 annual financial data

CytomX Therapeutics 2016 Financial results

CytomX Therapeutics 2016 financial results with verified reported values.

Direct answer

Revenue was 15,043,000 USD.

Operating income was -59,586,000 USD and net income was -58,900,000 USD.
Operating cash flow was -2,032,000 USD.

Get free CytomX Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
15,043,000 USD
Operating income
-59,586,000 USD
Net income
-58,900,000 USD
Operating cash flow
-2,032,000 USD